Log in
Create new account
home
boards
job center
archives
company monitor
cp wire
device news
pharmagather
advertise
contact us
Home
R256
AstraZeneca Set To Gain From New Asthma Drug
AstraZeneca Set To Gain From New Asthma Drug
Seeking Alpha
Amgen
asthma
AstraZeneca
Eli Lilly
GSK
JAK inhibitors
JNJ
Merck
R256
Rigel
AstraZeneca, Rigel Pharmaceuticals sign license agreement for R256
AstraZeneca, Rigel Pharmaceuticals sign license agreement for R256
Yahoo/Fly on the Wall
AstraZeneca
JAK inhibitors
R256
Rigel Pharmaceuticals
news tags
Abbott Laboratories
Amgen
Arena Pharmaceuticals
AstraZeneca
Bayer
Biogen Idec
biotech
Boston Scientific
Bristol-Myers Squibb
cancer
Celgene
China
Dendreon
diabetes
earnings
Eli Lilly
Europe
FDA
generics
Genzyme
GSK
hepatitis C
investors
JNJ
lawsuits
layoffs
M&A
Management
Medtronic
Merck
Novartis
obesity
patents
Pfizer
prostate cancer
Roche
Sanofi
Teva Pharmaceuticals
vaccines
Vivus
more tags
Yahoo! Finance
Quote for ABT